{"id":608132,"date":"2022-07-14T20:52:01","date_gmt":"2022-07-14T20:52:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=608132"},"modified":"2022-07-14T20:52:01","modified_gmt":"2022-07-14T20:52:01","slug":"covid19-diagnostics-market-report-2021-size-share-trends-analysis-and-forecast-till-2026","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/covid19-diagnostics-market-report-2021-size-share-trends-analysis-and-forecast-till-2026_608132.html","title":{"rendered":"COVID-19 Diagnostics Market Report 2021, Size, Share, Trends, Analysis and Forecast till 2026"},"content":{"rendered":"
\"COVID-19<\/a><\/div>\n
COVID-19 Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026<\/div>\n

According to the latest report by IMARC Group, titled “<\/strong>Covid-19 Diagnostics Market Share<\/strong><\/a>:<\/strong> Global Industry Trends, Size, Growth, Opportunity and Forecast 2021-2026”<\/strong> The global COVID-19 diagnostics market is expected to continue its strong growth during the next five years.<\/p>\n

COVID-19 represents an infectious disease caused by the newly discovered zoonotic coronavirus. Some of the common symptoms include fatigue, dry cough, fever, shortness of breath, sore throat, body aches, etc. COVID-19 diagnostics are clinical tests, such as reverse transcriptase-polymerase chain reaction (RT-PCR) and antigen-based as well as antibody testing that are conducted to detect the presence of viral infection among individuals. They use reagents and kits to obtain samples from oropharyngeal (OP), nasopharyngeal (NP), nasal swabs, human saliva or blood, etc. COVID-19 diagnostics find wide-ranging applications in laboratories, hospitals, clinics, research institutes, diagnostic centers, etc., across several countries.<\/p>\n

As the novel coronavirus (COVID-19)<\/strong> crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.<\/p>\n

Global Covid-19 Diagnostics Market Trends:<\/strong><\/p>\n

The escalating demand for mass testing is primarily driving the COVID-19 diagnostics market. Additionally, the growing number of daily cases has led to the widespread adoption of diagnostic tests for comprehensive examination to provide early treatment to the patients, which is also catalyzing the market growth. Besides this, the implementation of various stringent regulations by government bodies to prevent the sudden outbreak of the COVID-19 pandemic and extensive improvements in the healthcare infrastructures are acting as significant growth-inducing factors. Moreover, numerous product innovations, such as the introduction of novel antibody and serology test kits for home testing that are less time-consuming and can be integrated with software-based programs for accurate results, are anticipated to fuel the COVID-19 diagnostics market over the forecasted period.<\/p>\n

Request Free Sample Report: <\/strong>https:\/\/www.imarcgroup.com\/covid-19-diagnostics-market\/requestsample<\/strong><\/a><\/p>\n

Global Covid-19 Diagnostics Market 2021-2026 Analysis and Segmentation: <\/strong><\/p>\n

Competitive Landscape:<\/strong><\/p>\n

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.<\/p>\n

Abbott Laboratories, Becton Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Danaher Corporation, F. Hoffman-La Roche Ltd. (Roche Holding AG), Luminex Corporation, PerkinElmer Inc., Quest Diagnostics Incorporated, Robert Bosch GmbH, Seegene Inc., Siemens Aktiengesellschaft and Thermo Fisher Scientific Inc.<\/p>\n

The report has segmented the market on the basis on region, product type, sample type, test type, mode and end use.<\/p>\n

Breakup by Product Type:<\/strong><\/p>\n